Market research
300760.SHE Shenzhen Mindray Bio-Medical Electronics Co., Ltd
SHE CNY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 187B
- P/E ratio
- 23.85
- Analyst target
- 229.5088
- Dividend yield
- 1.9%
- Beta
- 0.18
Profile
Company facts
- Exchange
- SHE
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CNE100003G67
- Market cap
- 187B
- P/E ratio
- 23.85
- Analyst target
- 229.5088
- Dividend yield
- 1.9%
- Beta
- 0.18
About
About Shenzhen Mindray Bio-Medical Electronics Co., Ltd
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in China and internationally. The company offers various products, including patient monitoring, ultrasound, radiology, AED, defibrillation system, anesthesia, CLIA, chemistry, hematology, ventilators, electrocardiograph, endoscope camera system, operating tables, surgical lights, medical supply units, accessories, infusion system, orthopedics, IT Products, cardiovascular intervention, animal medical, and OEM products. It also provides various solutions, such as M-connect IT, M-connect ER, M-connect ICU, M-connect OR, and M-connect CCU solutions; advanced patient monitoring and intelligent ventilation, emergency ultrasound solutions, and fast defibrillation; customized pendant and critical care ultrasound solutions; precise anesthesia, minimally invasive surgery, infusion system, surgical lights, and anesthesia ultrasound solutions; laboratory diagnostics, medical imaging, and cybersecurity solutions. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 300760.SHE discussion.
5 years, 5 months ago
Shenzhen Mindray Bio-Medical Electronics Co., Ltd is currently in a long term uptrend where the price is trading 10.1% above its 200 day moving average.
From a valuation standpoint, the stock is 154.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 24.5.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd's total revenue rose by 31.8% to $5B since the same quarter in the previous year.
Its net income has increased by 46.7% to $2B since the same quarter in the previous year.
Finally, its free cash flow grew by 43.4% to $1B since the same quarter in the previous year.
Based on the above factors, Shenzhen Mindray Bio-Medical Electronics Co., Ltd gets an overall score of 4/5.